Identification and characterization of the human NOL7 gene promoter

Gene

Volumn 456, Issue 1-2, 2010, Pages 36-44

  Mankame, Tanmayi P ^a   Zhou, Guolin ^a   Lingen, Mark W ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

C Myc; NOL7; RXR ; TATA less promoter; Transcription

Indexed keywords

EXPORTIN 5; MYC PROTEIN; PROTEIN NOL7; RETINOID X RECEPTOR ALPHA; SIRTUIN 5; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BASE COMPOSITION; DNA LIBRARY; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION SITE; UPREGULATION; UTERINE CERVIX CANCER;

ANIMALS; BASE SEQUENCE; CELL LINE; GENE DELETION; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION, GENETIC;

EID: 77951093957     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2010.02.008     Document Type: Article

References (66)

1. Achuthan R., et al. Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone. Cancer Genet. Cytogenet. 2001, 130:166-172.
2. Altucci L., Leibowitz M.D., Ogilvie K.M., de Lera A.R., Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease. Nat. Rev. Drug Discov. 2007, 6:793-810.
3. Amare Kadam P.S., et al. Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma. Cancer Genet. Cytogenet. 2004, 150:33-43.
4. American Cancer Society I.: Cancer Facts and Figures 2009 2008, American Cancer Society, Inc., Atlanta.
5. Anish R., Hossain M.B., Jacobson R.H., Takada S. Characterization of transcription from TATA-less promoters: identification of a new core promoter element XCPE2 and analysis of factor requirements. PLoS ONE 2009, 4:e5103.
6. Arany I., Ember I.A., Tyring S.K. All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells. Anticancer Res. 2003, 23:471-473.
7. Arany I., Whitehead W.E., Ember I.A., Tyring S.K. Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells. Anticancer Res. 2003, 23:495-497.
8. Batanian J.R., et al. Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses. Mol. Pathol. 2002, 55:389-393.
9. Berlin Grace V.M., Niranjali Devaraj S., Radhakrishnan Pillai M., Devaraj H. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level. Gynecol. Oncol. 2006, 103:113-119.
10. Bernardi G. The human genome: organization and evolutionary history. Annu. Rev. Genet. 1995, 29:445-476.
11. Bernardi G. Isochores and the evolutionary genomics of vertebrates. Gene 2000, 241:3-17.
12. Biosystems, A., 2007. Relative Quantitation Using Comparative CT Getting Started Guide.
13. Bjornsdottir G., Myers L.C. Minimal components of the RNA polymerase II transcription apparatus determine the consensus TATA box. Nucleic Acids Res. 2008, 36:2906-2916.
14. Branca M., et al. Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. J. Clin. Pathol. 2006, 59:1044-1051.
15. Bugge T.H., Pohl J., Lonnoy O., Stunnenberg H.G. RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 1992, 11:1409-1418.
16. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 10:940-954.
17. Chatterjee A., et al. Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions. Cancer Res. 2001, 61:2119-2123.
18. Chen Z., Issa B., Brothman L.J., Hendricksen M., Button D., Brothman A.R. Nonrandom rearrangements of 6p in malignant hematological disorders. Cancer Genet. Cytogenet. 2000, 121:22-25.
19. Desvergne B., Gerald L. RXR: from partnership to leadership in metabolic regulations. Vitamins and Hormones 2007, 1-32. Academic Press.
20. Dong S.M., Kim H.S., Rha S.H., Sidransky D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res. 2001, 7:1982-1986.
21. Eilers M., Eisenman R.N. Myc’s broad reach. Genes Dev. 2008, 22:2755-2766.
22. Faluhelyi Z., Rodler I., Csejtey A., Tyring S.K., Ember I.A., Arany I. All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner. Anticancer Res. 2004, 24:807-809.
23. Fan Y.S., Rizkalla K. Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fluorescence in situ hybridization in lymphoma diagnosis. a summary of 154 cases. Cancer Genet. Cytogenet. 2003, 143:73-79.
24. Farre D., et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003, 31:3651-3653.
25. Fernandez P.C., et al. Genomic targets of the human c-Myc protein. Genes Dev. 2003, 17:1115-1129.
26. Fleischman E.W., et al. Chromosomal rearrangements with a common breakpoint at 6p23 in five cases of myeloid leukemia. Hum. Genet. 1983, 64:254-256.
27. Gasowska-Giszczak U., Darmochwal-Kolarz D., Kwasniewska A., Dziubinska-Parol I., Rolinski J., Oleszczuk J. Apoptosis of HeLa cell lines incubated with retinol. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005, 119:119-122.
28. Giagounidis A.A.N., Hildebrandt B., Heinsch M., Germing U., Aivado M., Aul C. Acute basophilic leukemia. Eur. J. Haematol. 2001, 67:72-76.
29. Guo J.M., et al. Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid. Int. J. Gynecol. Cancer 2006, 16:341-346.
30. Hasina R., et al. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene 2006, 25:588-598.
31. Hoyle C.F., Sherrington P., Hayhoe F.G. Translocation (3;6)(q21;p21) in acute myeloid leukemia with abnormal thrombopoiesis and basophilia. Cancer Genet. Cytogenet. 1988, 30:261-267.
32. Jadayel D., et al. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation. Leukemia 1995, 9:981-987.
33. Kaufmann A.M., Backsch C., Schneider A., Durst M. HPV induced cervical carcinogenesis: molecular basis and vaccine development. Zentralbl. Gynakol. 2002, 124:511-524.
34. Kim J., Lee J.H., Iyer V.R. Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS ONE 2008, 3:e1798.
35. Knutson D.C., Clagett-Dame M. atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion. Arch. Biochem. Biophys. 2008, 477:163-174.
36. Kuner R., et al. Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses. J. Mol. Med. 2007, 85:1253-1262.
37. Lazo P.A. The molecular genetics of cervical carcinoma. Br. J. Cancer 1999, 80:2008-2018.
38. Liao S.K., Perng Y.P., Shen Y.C., Chung P.J., Chang Y.S., Wang C.H. Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion. Cancer Genet. Cytogenet. 1998, 103:52-58.
39. Lim G., et al. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Cancer Genet. Cytogenet. 2004, 153:158-164.
40. Lingen M., Polverini P., Bouck N. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am. J. Pathol. 1996, 149:247-258.
41. Lung M.L., et al. Microsatellite allelotyping of chinese nasopharyngeal carcinomas. Anticancer Res. 2001, 21:3081-3084.
42. Majewski S., Szmurlo A., Marczak M., Jablonska S., Bollag W. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Int. J. Cancer 1994, 57:81-85.
43. Mazurenko N.N., et al. Cervical carcinoma progression-associated genetic alterations on chromosome 6. Mol. Biol. (Mosk.) 2003, 37:472-481.
44. Menssen A., Hermeking H. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. USA 2002, 99:6274-6279.
45. Messeguer X., Escudero R., Farre D., Nunez O., Martinez J., Alba M.M. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002, 18:333-334.
46. Mutirangura A., et al. Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection. Br. J. Cancer 1997, 76:770-776.
47. Nagai H., Kinoshita T., Suzuki H., Hatano S., Murate T., Saito H. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma. Genes Chromosom. Cancer 1999, 25:277-283.
48. Nakase K., Wakita Y., Minamikawa K., Yamaguchi T., Shiku H. Acute promyelocytic leukemia with del(6)(p23). Leuk. Res. 2000, 24:79-81.
49. Narisawa-Saito M., et al. An in vitro multistep carcinogenesis model for human cervical cancer. Cancer Res. 2008, 68:5699-5705.
50. Nemani M., Bellanne-Chantelot C., Cohen D., Cann H.M. Detection of triplet repeat sequences in yeast artificial chromosomes using oligonucleotide probes: application to the SCA1 region in 6p23. Cytogenet. Cell Genet. 1996, 72:5-8.
51. Pesole G., Bernardi G., Saccone C. Isochore specificity of AUG initiator context of human genes. FEBS Lett. 1999, 464:60-62.
52. Peter M., Rosty C., Couturier J., Radvanyi F., Teshima H., Sastre-Garau X. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 2006, 25:5985-5993.
53. Rader Janet S., Li Yan, Huettner Phyllis C., Xu Zhiqiang, Gerhard Daniela S. Cervical cancer suppressor gene is within 1cM on 6p23. Genes Chromosom. Cancer 2000, 27:373-379.
54. Rice P., Longden I., Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 2000, 16:276-277.
55. Roy B., Beamon J., Balint E., Reisman D. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol. 1994, 14:7805-7815.
56. Saavalainen K., Pasonen-Seppänen S., Dunlop T.W., Tammi R., Tammi M.I., Carlberg C. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. J. Biol. Chem. 2005, 280:14636-14644.
57. Sandelin A., Carninci P., Lenhard B., Ponjavic J., Hayashizaki Y., Hume D.A. Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat. Rev. Genet. 2007, 8:424-436.
58. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. Current Protocols in Bioinformatics 2003, J. Wiley and Sons. A.D. Baxevanis (Ed.).
59. Shao J.Y., et al. Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int. J. Oncol. 2000, 17:1267-1275.
60. Soucek L., et al. Modelling Myc inhibition as a cancer therapy. Nature 2008, 455:679-683.
61. Starostik P., et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002, 99:3-9.
62. Takeshita A., et al. Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia. Cancer Genet. Cytogenet. 2004, 152:56-60.
63. Walboomers J.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
64. Werner T. Computer-assisted analysis of transcription control regions. Matinspector and other programs. Meth. Mol. Biol. 2000, 132:337-349.
65. Zeller K.I., et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. USA 2006, 103:17834-17839.
66. Zhu J., He F., Hu S., Yu J. On the nature of human housekeeping genes. Trends Genet. 2008, 24:481-484.